Skip to content

Drug interactions

Pasireotide + Sunitinib

Severity: Moderate

Pasireotide and Sunitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, and pasireotide also causes bradycardia. Together they may raise the risk of torsades de pointes.

What this interaction means in plain words

Pasireotide and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pasireotide belongs to Endocrine; Sunitinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Monitor ECG at baseline and during treatment and correct potassium and magnesium. Reassess therapy if QTc increases substantially.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pasireotide and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pasireotide with Sunitinib?

MediHelp rates the interaction as moderate. Pasireotide and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, and pasireotide also causes bradycardia. Together they may raise the risk of torsades de pointes.

How serious is the interaction between Pasireotide and Sunitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG at baseline and during treatment and correct potassium and magnesium. Reassess therapy if QTc increases substantially.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in